Adverse Event reporting information can be found in footer

Request a Meeting

Next Event in:

Days

Hours

Minutes

Seconds

This meeting is organised and fully funded by Ferring Pharmaceuticals Ltd
Thu 23rd Sep 2021 - Fri 24th Sep 2021

Forest of Arden Marriott Hotel & Country Club
Maxstoke Lane,
Meriden
Birmingham,
CV7 7HR

IBD Doctors National Meeting 2021

"Clinical Challenges & Pearls In Contemporary IBD Care"

 

The Scientific Faculty and Ferring Pharmaceuticals are delighted to invite you to the IBD Doctors National Meeting 2021. The meeting will take place from the evening of 23rd September at the Forest of Arden Marriott Hotel & Country Club, Maxstoke Lane,  Meriden, Birmingham, CV7 7HR.

The meeting will bring the latest advances in clinical knowledge to well recognised clinical challenges in IBD. This includes the management of pregnant patients with IBD, management of patients with complex penetrating Crohn’s disease, and drug selection in ulcerative colitis; in an era of ever increasing choice. Speakers will explore how the latest data and guidelines can inform management decisions, all with lively and engaging audience discussion, and a few curve balls along the way…

Commissioned and sponsored by Ferring Pharmaceuticals. Ferring Pharmaceuticals has not been involved in the creation & development of the educational content for this meeting.

Agenda

September 22, 2021

8:00 pm - 8:50 pm
Registration and pre-dinner drinks
Session 1
Hosted by the Doctors Faculty
8:50 pm - 9:00 pm
Welcome and introduction
9:00 pm -
Dinner and interactive IBD challenge

September 23, 2021

9:00 am - 9:30 am
Registration
9:30 am - 9:40 am
Chair's Introduction
Session 2
Hosted by Dr Gareth Parkes
9:40 am - 9:50 am
The pregnant Crohn’s patient management - case description
Dr Gareth Parkes
9:50 am - 10:10 am
State of the art panel presentation: Treatment in pregnancy
Dr Klaartje Bel Kok, Aileen Fraser
agenda icon agenda popup icon
10:10 am - 10:40 am
Panel discussion followed by Q&A: Curve balls - perianal Crohn’s & flaring in pregnancy
Dr Klaartje Bel Kok, Aileen Fraser
10:40 am - 11:00 am
Patient’s perspective on reproductive health and IBD in pregnancy
Dr Klaartje Bel Kok, Aileen Fraser
11:00 am - 11:30 am
Coffee and check out
Session 3
Hosted by Dr Tim Raine
11:30 am - 11:40 am
The treatment naïve UC patient - case study
Dr Tim Raine
agenda icon agenda popup icon
11:40 am - 12:00 pm
State of the art panel presentation: Approach to drug selection in the multi-drug era
Professor Charlie Lees
agenda icon agenda popup icon
12:00 pm - 12:40 pm
Panel discussion on drug selection: Curve balls – patient with previous cancer, elderly patient, multi-morbidities
Dr Klaartje Bel Kok, Professor Charlie Lees
agenda popup icon
12:40 pm - 1:00 pm
How to compare drug efficacy in the absence of H2H studies: valid tools for the indirect comparison of drugs
Dr Nick Burr
agenda icon agenda popup icon
1:00 pm - 1:10 pm
Q&A
1:10 pm - 2:00 pm
Lunch
Session 4
Hosted by Dr Chris Lamb
2:00 pm - 2:50 pm
Defining and measuring of high-quality patient care in the UK (IBD standards)
Lisa Younge, Dr Chris Lamb
agenda icon agenda popup icon
2:50 pm - 3:00 pm
Q&A
Lisa Younge, Dr Chris Lamb
agenda icon agenda popup icon
3:00 pm - 3:30 pm
What have we learnt from COVID: results from UK studies
Dr Nick Kennedy
agenda icon agenda popup icon
3:30 pm - 4:10 pm
Panel discussion and Q&A: Incorporating lessons learnt into clinical practice
Dr Nick Kennedy, Professor Charlie Lees, Dr Chris Lamb, Dr Tim Raine
agenda popup icon
4:10 pm - 4:30 pm
State of the art presentation: IBD service recovery and development post-COVID (Tea/coffee & snacks provided during session)
Dr Shahida Din
agenda icon agenda popup icon
4:30 pm - 4:40 pm
Faculty wrap-up
4:40 pm -
Depart – coffee provided to take away

Speakers

Dr Klaartje Bel Kok

Consultant Gastroenterologist, Barts Health, Royal London Hospital, London

Aileen Fraser

IBD Clinical Nurse Specialist, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol

Professor Charlie Lees

Professor of Gastroenterology, University of Edinburgh and Consultant Gastroenterologist, Western General Hospital, Edinburgh

Dr Nick Burr

Clinical Research Fellow Leeds Gastroenterology Institute and Mid Yorkshire Hospitals NHS Trust, Wakefield

Lisa Younge

IBD Nurse Consultant, St Mark’s Hospital, North West Healthcare NHS Trust, London

Dr Nick Kennedy

Gastrointestinal and Liver Services, Royal Devon and Exeter NHS Foundation Trust, Devon

Dr Chris Lamb

Consultant Gastroenterologist, The Royal Victoria Hospital, Newcastle

Dr Gareth Parkes

Consultant Gastroenterologist, Royal London Hospital, London

Dr Tim Raine

Consultant Gastroenterologist, Addenbrooke’s Hospital, Cambridge

Dr Shahida Din

Consultant Gastroenterologist, NHS Lothian, Edinburgh

Meet the FacultyClick faculty images for biographies

Dr Gareth Parkes

Gareth trained at Cambridge, Bart’s & the London and studied for a PhD at King’s College London, examining the role of the gut bacteria in the development of irritable bowel syndrome. He now works as a Consultant Gastroenterologist at the Royal London Hospital where he is a core member of the IBD team. His interests include Irritable Bowel Syndrome (IBS), Crohn’s disease, Ulcerative Colitis, probiotics and low FODMAP diets in IBS as well as indigestion and heartburn. Gareth sits on the British Society of Gastroenterology IBD committee, has a number of publications in the field of IBS and IBD and reviews papers for Alimentary Pharmacology & Therapeutics (APT), Neurogastromotility and the Annals of Gastroenterology. He is actively involved as a chief investigator in commercial clinical trials and has developed the UK’s first mobile phone App for patients with IBD ‐ ‘My IBD Care’.

Dr Chris Lamb

Chris Lamb is an academic gastroenterologist working as an Honorary Consultant in Gastroenterology at the Newcastle upon Tyne Hospitals NHS Foundation Trust and a Clinical Intermediate Fellow at Newcastle University. A former NIHR Clinical Lecturer and previous Wellcome Trust Clinical Fellow in Translational Medicine and Therapeutics he has a clinical and research specialist interest in inflammatory bowel disease.

Chris leads a mucosal immunology research programme that studies biological signatures of inflammation aiming to inform existing treatment stratification, the development of novel, or repurposing of existing therapies, and innovative clinical trial design to benefit patients through contributing to precision medicine strategies. In addition he has an interest in evidence synthesis and for the last 3 years along with a multidisciplinary group of UK IBD clinicians and patients he has led the development of the British Society of Gastroenterology (BSG) guidelines on management of IBD in adults. Chris is a previous recipient of the award Young Gastroenterologist of the Year: Emerging Leader from the BSG, and was previously awarded the BSG President’s medal by Sir Ian Gilmore. He is a current member of the IBD Section of the BSG and has previously Chaired the Trainees Section Committee, and been a member of the Training Committee, Education Committee and Council of the BSG.

Dr Tim Raine

Tim Raine is a consultant gastroenterologist and clinical lead for IBD at Addenbrooke’s Hospital, Cambridge, UK. Tim is a member of the ECCO (European Crohn’s and Colitis Organisation) guidelines committee, and an author and group leader on several current ECCO guidelines. He serves on the British Society of Gastroenterology (BSG) IBD Clinical Research Group and was awarded BSG Young Gastroenterologist of the Year 2016. Tim has an interest in clinical trials and is lead investigator of several studies including the major UK IASO trial in acute-severe colitis. His research, funded by the Wellcome Trust, CCFA, OpenTargets and the National Institute for Health Research, focuses on regulation of the gastrointestinal immune system. Tim is an honorary faculty member of the Wellcome Trust Sanger Centre, UK.

Gareth trained at Cambridge, Bart’s & the London and studied for a PhD at King’s College London, examining the role of the gut bacteria in the development of irritable bowel syndrome. He now works as a Consultant Gastroenterologist at the Royal London Hospital where he is a core member of the IBD team. His interests include Irritable Bowel Syndrome (IBS), Crohn’s disease, Ulcerative Colitis, probiotics and low FODMAP diets in IBS as well as indigestion and heartburn. Gareth sits on the British Society of Gastroenterology IBD committee, has a number of publications in the field of IBS and IBD and reviews papers for Alimentary Pharmacology & Therapeutics (APT), Neurogastromotility and the Annals of Gastroenterology. He is actively involved as a chief investigator in commercial clinical trials and has developed the UK’s first mobile phone App for patients with IBD ‐ ‘My IBD Care’.

Chris Lamb is an academic gastroenterologist working as an Honorary Consultant in Gastroenterology at the Newcastle upon Tyne Hospitals NHS Foundation Trust and a Clinical Intermediate Fellow at Newcastle University. A former NIHR Clinical Lecturer and previous Wellcome Trust Clinical Fellow in Translational Medicine and Therapeutics he has a clinical and research specialist interest in inflammatory bowel disease.

Chris leads a mucosal immunology research programme that studies biological signatures of inflammation aiming to inform existing treatment stratification, the development of novel, or repurposing of existing therapies, and innovative clinical trial design to benefit patients through contributing to precision medicine strategies. In addition he has an interest in evidence synthesis and for the last 3 years along with a multidisciplinary group of UK IBD clinicians and patients he has led the development of the British Society of Gastroenterology (BSG) guidelines on management of IBD in adults. Chris is a previous recipient of the award Young Gastroenterologist of the Year: Emerging Leader from the BSG, and was previously awarded the BSG President’s medal by Sir Ian Gilmore. He is a current member of the IBD Section of the BSG and has previously Chaired the Trainees Section Committee, and been a member of the Training Committee, Education Committee and Council of the BSG.

Tim Raine is a consultant gastroenterologist and clinical lead for IBD at Addenbrooke’s Hospital, Cambridge, UK. Tim is a member of the ECCO (European Crohn’s and Colitis Organisation) guidelines committee, and an author and group leader on several current ECCO guidelines. He serves on the British Society of Gastroenterology (BSG) IBD Clinical Research Group and was awarded BSG Young Gastroenterologist of the Year 2016. Tim has an interest in clinical trials and is lead investigator of several studies including the major UK IASO trial in acute-severe colitis. His research, funded by the Wellcome Trust, CCFA, OpenTargets and the National Institute for Health Research, focuses on regulation of the gastrointestinal immune system. Tim is an honorary faculty member of the Wellcome Trust Sanger Centre, UK.

Meet the SpeakersClick the speaker for their biography

Dr Nick Burr

Dr Burr is a Clinical Research Fellow at the University of Leeds, and final year Specialist Registrar. He has been a clinical academic trainee in Yorkshire since moving from East Anglia in 2014. HIs main clinical and academic interests are Inflammatory Bowel Diseases and Colorectal Cancer.

Dr Burr has tried to answer clinically relevant questions with the use of population-level data, and evidence synthesis using meta-analysis. With the academic team in Leeds, we have developed a protocol for network meta-analysis. This gives a ranking or hierarchy of treatments which may not have been compared “head-to-head” in a clinical trial. We have published several articles in Gut, Gastroenterology and the Lancet Gastroenterology and Hepatology recently.

Dr Shahida Din

Shahida Din is a Consultant Gastroenterologist at the Western General Hospital in Edinburgh and a National Research Scotland Clinician leading clinical trials and a programme of work to improve the detection of colonic epithelial dysplasia/colorectal cancer in patients with inflammatory bowel diseases. Shahida is leading a Scottish Government led working group to standardise IBD Surveillance procedures.
In 2019, Shahida was jointly awarded a Helmsley Charitable Trust Grant to develop the Crohn’s Disease Gut Cell Atlas with her collaborators in Edinburgh and Cambridge. Shahida is a member of the BSG IBD Committee and Gastroenterology specialty advisor to the RCPE and lead author of the adaptations of the BSG ASUC guidelines and clinical service recovery during the pandemic.

Aileen Fraser

Aileen Fraser, an IBD Advanced Clinical Practitioner, leads the IBD nursing service University Hospitals Bristol, where she has been in post since 2001. She has an MSc in advanced practice in healthcare, completing this with a dissertation on sexual dysfunction in pouch patients In addition to her clinical practice, Aileen has also made contributions to IBD research and was a member of the BSG IBD committee involved in writing the 2019 BSG IBD Clinical Guidelines. She was also one of the authors of the 2007 IBD nurse role descriptives document.

Since taking up post as the IBD CNS for the trust Aileen has been active within the IBD nurse community, chairing the Severnside regional IBD nurse group and having been secretary and now current for the RCN national IBD nurse group . She was also previously an RCN IBD Forum representatives on the BSG IBD Section Committee.

Her other interests include managing patient expectations, transition of young patients, pregnancy, iron deficiency and the effect of insomnia on fatigue levels in the IBD community.

Dr Nick Kennedy

Dr Nick Kennedy (MBBS FRACP MA Hons) is a Consultant Gastroenterologist at the Royal Devon and Exeter Hospital, and Honorary Clinical Senior Lecturer at the University of Exeter. He obtained his Ph.D. in Medicine at The University of Edinburgh.

His clinical and research interests are in inflammatory bowel disease (IBD; Crohn’s disease and ulcerative colitis), particularly in understanding treatment response in IBD. He has coordinated large multi-site research projects to assess the contributions of genetics, epigenetics, and the gut microbiota to the development, progression, and treatment response in IBD.

He is a member of the UK and international IBD genetics consortia, sits on the British Society of Gastroenterology (BSG) IBD clinical research and guidelines groups, and is an associate editor of Alimentary Pharmacology & Therapeutics. He is a key author of the BSG guidance and risk assessment for IBD patients during the COVID-19 pandemic and has conducted several studies to help understand the impact of IBD and its treatments on COVID-19.

Dr Burr is a Clinical Research Fellow at the University of Leeds, and final year Specialist Registrar. He has been a clinical academic trainee in Yorkshire since moving from East Anglia in 2014. HIs main clinical and academic interests are Inflammatory Bowel Diseases and Colorectal Cancer.

Dr Burr has tried to answer clinically relevant questions with the use of population-level data, and evidence synthesis using meta-analysis. With the academic team in Leeds, we have developed a protocol for network meta-analysis. This gives a ranking or hierarchy of treatments which may not have been compared “head-to-head” in a clinical trial. We have published several articles in Gut, Gastroenterology and the Lancet Gastroenterology and Hepatology recently.

Shahida Din is a Consultant Gastroenterologist at the Western General Hospital in Edinburgh and a National Research Scotland Clinician leading clinical trials and a programme of work to improve the detection of colonic epithelial dysplasia/colorectal cancer in patients with inflammatory bowel diseases. Shahida is leading a Scottish Government led working group to standardise IBD Surveillance procedures.
In 2019, Shahida was jointly awarded a Helmsley Charitable Trust Grant to develop the Crohn’s Disease Gut Cell Atlas with her collaborators in Edinburgh and Cambridge. Shahida is a member of the BSG IBD Committee and Gastroenterology specialty advisor to the RCPE and lead author of the adaptations of the BSG ASUC guidelines and clinical service recovery during the pandemic.

Aileen Fraser, an IBD Advanced Clinical Practitioner, leads the IBD nursing service University Hospitals Bristol, where she has been in post since 2001. She has an MSc in advanced practice in healthcare, completing this with a dissertation on sexual dysfunction in pouch patients In addition to her clinical practice, Aileen has also made contributions to IBD research and was a member of the BSG IBD committee involved in writing the 2019 BSG IBD Clinical Guidelines. She was also one of the authors of the 2007 IBD nurse role descriptives document.

Since taking up post as the IBD CNS for the trust Aileen has been active within the IBD nurse community, chairing the Severnside regional IBD nurse group and having been secretary and now current for the RCN national IBD nurse group . She was also previously an RCN IBD Forum representatives on the BSG IBD Section Committee.

Her other interests include managing patient expectations, transition of young patients, pregnancy, iron deficiency and the effect of insomnia on fatigue levels in the IBD community.

Dr Nick Kennedy (MBBS FRACP MA Hons) is a Consultant Gastroenterologist at the Royal Devon and Exeter Hospital, and Honorary Clinical Senior Lecturer at the University of Exeter. He obtained his Ph.D. in Medicine at The University of Edinburgh.

His clinical and research interests are in inflammatory bowel disease (IBD; Crohn’s disease and ulcerative colitis), particularly in understanding treatment response in IBD. He has coordinated large multi-site research projects to assess the contributions of genetics, epigenetics, and the gut microbiota to the development, progression, and treatment response in IBD.

He is a member of the UK and international IBD genetics consortia, sits on the British Society of Gastroenterology (BSG) IBD clinical research and guidelines groups, and is an associate editor of Alimentary Pharmacology & Therapeutics. He is a key author of the BSG guidance and risk assessment for IBD patients during the COVID-19 pandemic and has conducted several studies to help understand the impact of IBD and its treatments on COVID-19.

Dr Klaartje Bel Kok

Dr Klaartje Bel Kok, MBBM MRCP PhD trained at the AMC, Amsterdam, and studied for a PhD at UCL (Ludwig Institute), London. She now works as a Consultant Gastroenterologist at Barts Health, the Royal London Hospital where she is a core member of the IBD team. Her interests include IBD, IBD in young adults and pregnancy, as well as intestinal failure. Bel sits on the United European Gastroenterology Education committee and has a number of publications and book chapters in the field of IBD and she reviews papers for several journals. She is a Honorary Senior Clinical Lecturer at Queen Mary University of London and is a chief investigator for IBD translational research and investigator led clinical trials.

Prof. Charlie Lees

Charlie is Professor of Gastroenterology at the University of Edinburgh, a UK Research and Innovation Future Leaders Fellow (UKRIFLF) and Consultant Gastroenterologist in the Edinburgh IBD Unit.

In 2019 Charlie was awarded the UKRIFLF, a personal fellowship worth £1.7m that enabled his transition to full-time academic gastroenterology. His core mission is to improve outcomes for people living with IBD and together with his team, is working on predicting outcomes in IBD through the PREdiCCt study where he is the Chief Investigator. In addition to predicting outcomes, Charlie is integrating health apps and working with industry partners to disrupt IBD care through digital technologies and data driven innovation.

Charlie is a passionate educator lecturing widely about the current and future management of IBD, the causes and consequences of IBD, telemedicine and digital health.

Lisa Younge

Lisa is an IBD Nurse Consultant working at St Marks Hospital. She has over 15 years’ experience working as an inflammatory bowel disease nurse specialist and has been responsible for the creation of and subsequent development of IBD nursing services at a number of London hospitals prior to taking up her current post.

Lisa completed her nurse training at the North London College of Health Studies, London, UK, and has subsequently completed an MSc in Advanced Nursing Practice, undertaking an audit of satisfaction levels with service delivery amongst older people living with IBD.

Her publications include journal articles and chapters on topics including IBD treatment and the contribution of specialist nurses to the management and support of patients with inflammatory bowel disease, and she is actively involved with the education of both pre and post registration nurses regarding management of IBD. She has served as a committee member on the Royal College of Nursing IBD Special Interest group, British Society of Gastroenterology IBD Section and NECCO, including 5 years as the Chair of NECCO from 2008 ‐ 2013.

In March 2019 she started working with Crohn’s and Colitis UK for two days a week as Project Manager, IBD nursing, and is currently one of the Royal College of Nursing representatives in IBDUK, an organisation committed to standardising care for people with IBD throughout the UK.

Dr Klaartje Bel Kok, MBBM MRCP PhD trained at the AMC, Amsterdam, and studied for a PhD at UCL (Ludwig Institute), London. She now works as a Consultant Gastroenterologist at Barts Health, the Royal London Hospital where she is a core member of the IBD team. Her interests include IBD, IBD in young adults and pregnancy, as well as intestinal failure. Bel sits on the United European Gastroenterology Education committee and has a number of publications and book chapters in the field of IBD and she reviews papers for several journals. She is a Honorary Senior Clinical Lecturer at Queen Mary University of London and is a chief investigator for IBD translational research and investigator led clinical trials.

Charlie is Professor of Gastroenterology at the University of Edinburgh, a UK Research and Innovation Future Leaders Fellow (UKRIFLF) and Consultant Gastroenterologist in the Edinburgh IBD Unit.

In 2019 Charlie was awarded the UKRIFLF, a personal fellowship worth £1.7m that enabled his transition to full-time academic gastroenterology. His core mission is to improve outcomes for people living with IBD and together with his team, is working on predicting outcomes in IBD through the PREdiCCt study where he is the Chief Investigator. In addition to predicting outcomes, Charlie is integrating health apps and working with industry partners to disrupt IBD care through digital technologies and data driven innovation.

Charlie is a passionate educator lecturing widely about the current and future management of IBD, the causes and consequences of IBD, telemedicine and digital health.

Lisa is an IBD Nurse Consultant working at St Marks Hospital. She has over 15 years’ experience working as an inflammatory bowel disease nurse specialist and has been responsible for the creation of and subsequent development of IBD nursing services at a number of London hospitals prior to taking up her current post.

Lisa completed her nurse training at the North London College of Health Studies, London, UK, and has subsequently completed an MSc in Advanced Nursing Practice, undertaking an audit of satisfaction levels with service delivery amongst older people living with IBD.

Her publications include journal articles and chapters on topics including IBD treatment and the contribution of specialist nurses to the management and support of patients with inflammatory bowel disease, and she is actively involved with the education of both pre and post registration nurses regarding management of IBD. She has served as a committee member on the Royal College of Nursing IBD Special Interest group, British Society of Gastroenterology IBD Section and NECCO, including 5 years as the Chair of NECCO from 2008 ‐ 2013.

In March 2019 she started working with Crohn’s and Colitis UK for two days a week as Project Manager, IBD nursing, and is currently one of the Royal College of Nursing representatives in IBDUK, an organisation committed to standardising care for people with IBD throughout the UK.

PRESCRIBING INFORMATION

Job Code: UK-GAS-2000011 - Date of preparation: July 2022

cookiepopup

Our use of cookies

We use cookies (including third party cookies) to collect data while you use this website in order to make it work, keep it secure and comply with regulations. We’d also like your consent to use cookies so we can provide you with tailored content and advertising and analyse how you and other people use the website.

Select “On” to consent to our use of these cookies and continue to the website, or select “Off” to control which types of cookies we use. You can read more about cookies in our Privacy Policy.

Necessary cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics cookies

We’d like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in away that does not directly identify anyone. For more information on how these cookies work, please see our Privacy Policy.